Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
-
Legal situation KBO
Opening faillissement according to the CBE.
Financials
Financial year 2023
DALE Pharma from Enghien, company number BE0791839803, closed financial year 2023 with a result of € 716 after tax. For that financial year DALE Pharma recorded revenue of € 3.3 million and equity of € 606,013. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 15, 2024.
€ 606,013
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 716
Profit after tax over the fiscal year.
€ 33,594
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2023. Retained profit grew to € 716.
People and assets in 2023
17.6
Average over the fiscal year, from the social balance sheet.
€ 1.2 million
€ 68,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 139,776
Book value of vehicles, furniture and equipment.
Debts at end 2023
€ 901,691
€ 180,508 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 1.2 million
Supplier invoices still open on the last day of the fiscal year.
€ 244,538
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to DALE Pharma?
What happened at DALE Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
DALE Pharma is active according to the CBE. Legal situation: Opening faillissement.
- New annual accounts for financial year 2023: profit of € 716. filed late Source: NBB ↗
- New establishment in Sambreville. KBO
- New establishment in Enghien. KBO
- Start of the company according to the CBE. KBO
In short
On average € 73,900 of value added per employee in 2023.
A new publication or filing at DALE Pharma? We notify you, reason included.
Follow DALE PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Grote Plaats(E) 50
7850 Enghien
Avenue de la Libération(AUV) 63
5060 Sambreville
Active since 1 December 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →FEEL I.T.
€ 23,944 gross margin · 2024
BYGHY CONSTRUCT
€ 49,496 gross margin · 2025
The Mug Enghien
€ 222,079 gross margin · 2025
AG-fix-IT
€ 3,944 gross margin · 2025
EGOMATIC
€ 8,967 gross margin · 2025
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0791.839.803
- VAT number
- BE 0791.839.803
- Registered office
- Grote Plaats(E) 50, 7850 Enghien
- Names & denominations
- DALE Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 4 October 2022
- Peppol
- Not registered
- Contact
- [email protected] 0456791614
- Activities · NACE
Overige niet-gespecialiseerde detailhandel
Detailhandel via postorderbedrijven of via internet
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels